Business Summary

Company manufactures and distributies pharmaceutical products which including drugs, infusion and injectables. Read More

NGX Chart


KEY STATISTICS


VALUATION MEASURES
 
Market Cap (intraday): 98.68B
Price/Sales (ttm): 1.17
Price/Book (mrq): 4.16
Debt/Equity: 43.26 %
P/E (ttm): 17.08
BVPS: 10.34

FINANCIAL HIGHLIGHTS
 
Fiscal Year
Fiscal Year Ends: 31 Dec

Income Statement
Revenue (ttm): 84.18B
Revenue Per Share (ttm): 37
Gross Profit (ttm): 35.10B
Profit Before tax (ttm): 07.70B
Net Income Avl to Common (ttm): 05.78B

Balance Sheet
Total Cash (mrq): 04.93B
Shareholders Equity (mrq): 23.73B
Total Debt (mrq): 10.26B
TOTAL ASSETS: 73.49B
TOTAL LIABILITIES: 49.77B
 
 


TRADING INFORMATION
 
Stock Price History
Beta: N/A
52-Week High : 47
52-Week Low : 13
50-Day Moving Average: 43.58
200-Day Moving Average: 23.07

Share Statistics
Average Volume (3 month): 1,016,848
Shares Outstanding: 02.29B


Note:
*ttm: trailing twelve months
*mrq : most recent quarter
Copyright @ 2010-2025 Easykobo.com by Naija infotech & solar energy ltd. All rights reserved